Skyhawk Therapeutics
Waltham
About Skyhawk Therapeutics
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use proprietary technology that helps the rational design of small molecules that target specific binding pocket regions on RNA, using both sequence and structural specificity, at particular moments in the RNA splicing process, enabling physicians to target diseases driven by a type of RNA mis-splicing called exon skipping.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $181.2M
- Last round: Series Unknown (Sep 2021)
- Website: skyhawktx.com
- Phone: 617.858.0041
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/skyhawk-therapeutics-96381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.